Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC

Journal of Neuroimmunology

Volumn 166, Issue 1-2, 2005, Pages 144-157

  Torres, Karen C L ^a   Antonelli, Lis R V ^a   Souza, Adriano L S ^a   Teixeira, Mauro M ^a   Dutra, Walderez O ^a   Gollob, Kenneth J ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cytokines; Dexamethasone; Dopamine; Norepinephrine; PBMC; T cell

Indexed keywords

CATECHOLAMINE; CHEMOKINE; CYTOKINE; DEXAMETHASONE; DOPAMINE; GLUCOCORTICOID; NORADRENALIN;

ADULT; ARTICLE; CELL ACTIVATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LEUKOCYTE; LEUKOCYTE ACTIVATION; LYMPHOCYTE ACTIVATION; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; TH1 CELL; TH2 CELL;

ADULT; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; DOPAMINE; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MONOCYTES; NOREPINEPHRINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH2 CELLS;

EID: 23044490894     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.06.006     Document Type: Article

References (34)

1. S.K. Agarwal, and G.D. Marshall Jr. Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction J. Interferon Cytokine Res. 18 1998 1059 1068
2. J.D. Ashwell, F.W. Lu, and M.S. Vacchio Glucocorticoids in T cell development and function Annu. Rev. Immunol. 18 2000 309 345
3. S. Basu, and P.S. Dasgupta Dopamine, a neurotransmitter, influences the immune system J. Neuroimmunol. 102 2000 113 124
4. O.A. Batuman, A.P. Ferrero, A. Diaz, B. Berger, and R.J. Pomerantz Glucocorticoid-mediated inhibition of interleukin-2 receptor alpha and -beta subunit expression by human T cells Immunopharmacology 27 1994 43 55
5. H. Bessler, R. Djaldetti, H. Salman, M. Bergman, and M. Djaldetti IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease Biomed. Pharmacother. 53 1999 141 145
6. R.L. Bottrel, W.O. Dutra, F.A. Martins, B. Gontijo, E. Carvalho, M. Barral-Netto, A. Barral, R.P. Almeida, W. Mayrink, R. Locksley, and K.J. Gollob Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis Infect. Immun. 69 2001 3232 3239
7. L. Carr, A. Tucker, and R. Fernandez-Botran In vivo administration of L-dopa or dopamine decreases the number of splenic IFN gamma-producing cells J. Neuroimmunol. 137 2003 87 93
8. G.A. Carrasco, and L.D. Van de Kar Neuroendocrine pharmacology of stress Eur. J. Pharmacol. 463 2003 235 272
9. F.S. Dhabhar Stress-induced augmentation of immune function - the role of stress hormones, leukocyte trafficking, and cytokines Brain Behav. Immun. 16 2002 785 798
10. I.J. Elenkov, R.L. Wilder, G.P. Chrousos, and E.S. Vizi The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system Pharmacol. Rev. 52 2000 595 638
11. C. Ewen, and M.E. Baca-Estrada Evaluation of interleukin-4 concentration by ELISA is influenced by the consumption of IL-4 by cultured cells J. Interferon Cytokine Res. 21 2001 39 43
12. D. Franchimont, J. Galon, M. Gadina, R. Visconti, Y. Zhou, M. Aringer, D.M. Frucht, G.P. Chrousos, and J.J. O'shea Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes J. Immunol. 164 2000 1768 1774
13. J. Galon, D. Franchimont, N. Hiroi, G. Frey, A. Boettner, M. Ehrhart-Bornstein, J.J. O'shea, G.P. Chrousos, and S.R. Bornstein Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells FASEB J. 16 2002 61 71
14. X. Gan, L. Zhang, G.F. Solomon, and B. Bonavida Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity Brain Behav. Immun. 16 2002 227 246
15. M.C. Ghosh, A.C. Mondal, S. Basu, S. Banerjee, J. Majumder, D. Bhattacharya, and P.S. Dasgupta Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells Int. Immunopharmacol. 3 2003 1019 1026
16. + T cell cultures Eur. J. Immunol. 26 1996 1565 1570
17. J.J. Haddad, N.E. Saade, and B. Safieh-Garabedian Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary- adrenal revolving axis J. Neuroimmunol. 133 2002 1 19
18. D. Haller, P. Serrant, G. Peruisseau, C. Bode, W.P. Hammes, E. Schiffrin, and S. Blum IL-10 producing CD14low monocytes inhibit lymphocyte-dependent activation of intestinal epithelial cells by commensal bacteria Microbiol. Immunol. 46 2002 195 205
19. G. Hasko, and C. Szabo Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system Biochem. Pharmacol. 56 1998 1079 1087
20. G. Hasko, T.P. Shanley, G. Egnaczyk, Z.H. Nemeth, A.L. Salzman, E.S. Vizi, and C. Szabo Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism Br. J. Pharmacol. 125 1998 1297 1303
21. G. Hasko, C. Szabo, Z.H. Nemeth, and E.A. Deitch Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism J. Neuroimmunol. 122 2002 34 39
22. V.V. Kalinichenko, M.B. Mokyr, L.H.J. Graf, R.L. Cohen, and D.A. Chambers Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene expression J. Immunol. 163 1999 2492 2499
23. A.P. Kohm, and V.M. Sanders Norepinephrine: a messenger from the brain to the immune system Immunol. Today 21 2000 539 542
24. + T and B lymphocyte function in vitro and in vivo Pharmacol. Rev. 53 2001 487 525
25. F. McKenna, P.J. McLaughlin, B.J. Lewis, G.C. Sibbring, J.A. Cummerson, D. Bowen-Jones, and R.J. Moots Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study J. Neuroimmunol. 132 2002 34 40
26. J.A. Moynihan Mechanisms of stress-induced modulation of immunity Brain Behav. Immun. Suppl 1 2003 S11 S16
27. J. Moynihan, B. Kruszewska, K. Madden, and T. Callahan Sympathetic nervous system regulation of immunity J. Neuroimmunol. 147 2004 87 90
28. N.R. Musso, S. Brenci, M. Setti, F. Indiveri, and G. Lotti Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes J. Clin Endocrinol Metab. 81 1996 3553 3557
29. D.S. Ramer-Quinn, R.A. Baker, and V.M. Sanders Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production J. Immunol. 159 1997 4857 4867
30. C. Roupe van der Voort, C.J. Heijnen, N. Wulffraat, W. Kuis, A. Kavelaars, and M. Wahle Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for alpha(1)-adrenergic receptors J. Neuroimmunol. 110 2000 223 229
31. V.M. Sanders, and R.H. Straub Norepinephrine, the beta-adrenergic receptor, and immunity Brain Behav. Immun. 16 2002 290 332
32. + T helper cells Hum. Immunol. 65 2004 1328 1335
33. M. Wahle, U. Stachetzki, A. Krause, M. Pierer, H. Hantzschel, and C.G. Baerwald Regulation of beta2-adrenergic receptors on CD4 and CD8 positive lymphocytes by cytokines in vitro Cytokine 16 2001 205 209
34. J.I. Webster, L. Tonelli, and E.M. Sternberg Neuroendocrine regulation of immunity Annu. Rev. Immunol. 20 2002 125 163